Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melan...
Leadership
David P. Meeker M.D.
Chairman, President & CEO
Hunter C. Smith M.B.A.
CFO & Treasurer
Alastair Garfield Ph.D.
Chief Scientific Officer
Yann Mazabraud
Executive VP & Head of International
Jennifer Lee
Executive VP & Head of North America
Christopher P. German
Corporate Controller & Principal Accounting Officer
Joseph Shulman
Chief Technical Officer
David Connolly
Head of Investor Relations & Corporate Communications
